DePuy Synthes Products, Inc. develops and markets medical products. It offers distal volar Radius, which is designed to treat distal radius fractures, dorsal endoplate, an invasive dorsal nail plate that provides fixed angle support and intramedullary locked fixation with a duplicate and reproducible surgical procedure, spatial subchondral support plate, which is used to treat proximal humeral fractures and Small Bone Fixation System, a percutaneous locked intramedullary nail system for metacarpals and the phalanges. The company was founded on June 22, 2004 and is headquartered in Wilmington, DE.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. It’s original remit was to provide skin and scar cells to laboratories around the world for research, as well as to perform contract research for cell laboratories internationally. In 2004, our scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date we have patents granted in multiple strategic key territories around the world. The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy. Considerable headway has already been achieved, and we are due shortly to start USFDA Clinical Trials with our collaborators in the USA, leading to a therapy to accelerate wound healing. To maximise future Cord Lining Stem Cell use, CellResearch Corporation feels that the membrane from which the cells are derived should be stored. Today we license our proprietary technology to partners who bank Cord Lining Membrane in various territories around the world. Our extensive experience with Cord Lining Stem Cells has taught us much, and we have been able to utilise this knowledge to produce a ground breaking cosmeceutical line called CALECIM® which has been observed to improve the skin appearance after topical application.

Tissue Technologies, Inc., part of Cynosure LLC, is a company headquartered in the United States that develops and makes cosmetic laser systems. The firm was acquired by Palomar Medical Technologies LLC, a subsidiary of Cynosure LLC since June 2013, on May 08, 1996 for $34.50 million.

LifeScan manufactures and markets blood glucose monitoring systems. The company’s product portfolio includes blood glucose meters, test strips, lancing devices, and diabetes management software solutions, hospital meters, data management systems, glucose control solutions, and linearity test kits. Additionally, the company provides pre-installation project management, installation, and post installation support services, including on-site and on-line training programs through authorized distributors such as doctors, pharmacists, and diabetes educators. Lifescan was founded in 1981 and is headquartered in Milpitas, California.  The company currently operates as a subsidiary of Johnson & Johnson and has facilities in Inverness, Scotland; Burnaby, British Columbia, Canada; and Cabo Rojo, Puerto Rico.

Jilin Tuohua Biotechnology Co., Ltd., established on 2010-12-31, Business scope includes research and development of biomedical technology,consult,transfer,Serve;Cell Technology Services,Tissue storage service,Exhibition display service,Reagent sales(Does not contain dangerous goods);Acquisition of agricultural and sideline products;Cosmetic production;cosmetic;Health Products Sales;consultation service,Cleaning Products;Daily necessities sales;Medical device production;Sales;lease;Investment and management of medical institutions;Research and development of biological gene detection technology;consult;Serve;disinfection products(Does not contain dangerous goods)Production;Sales;(The following items are limited to branch operations)Hemodialysis Technology;beauty service;chemical reagent(Does not contain dangerous goods)Production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Dongzhi Medical Technology (Shanghai) Co., Ltd., established on 2018-12-11, Business scope includes licensed projects:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:working in medical technology,Biotechnology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technology development in the field,technology transfer,technical consulting,Technical Services,medical instruments,Research and development of food additives,Class I medical device,Manufacturing and sales of cosmetics,Class II Medical Devices,Instrumentation,Equipment,Electronic equipment,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,Research and development of biological reagents for non-clinical diagnosis,Sales,Business Management Consulting,marketing planning,Import and export,Technology Import and Export .(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hexie Technology Co., Ltd., established on 2017-10-24, Business scope includes technical services,technology transfer,technology development,Technology Promotion,technical consulting;Natural science research and experimental development;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;software development;Computer System Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);market survey;Business Management Consulting;Economic and Trade Consulting;health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);Sales of chemical reagents,Class Ι medical device,IIkind,cosmetic,sporting goods,Fitness Equipment;Production No.Iclass of medical devices;Technology intermediary service;Import and export;Agent import and export;Technology Import and Export;trade agent;sell food;Sales No.IIIclass of medical devices;Production No.IIkind,No.IIIclass of medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Production No.IIkind,No.IIIclass of medical devices,Sales No.IIIClass medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Healthbanks Biotech Co., Ltd. is a Taiwanese private company located in Taipei. The firm manufactures pharmaceutical products.

Kesorui Biotechnology (Tianjin) Co., Ltd., established on 2018-05-07, Business scope includes biotechnology development,Technical Services,technology transfer,technical consulting;Biotechnology Extension Services;stem cell technology,Stem Cell Drug Technology,cosmetic,Technology development of skin care products;Medical Research;cosmetic,skin care products,Laboratory equipment,Chemical Products(Strong drug,chemical hazards,Precursor Drugs Excluded)Wholesale and retail;Import and export of goods and technology;Medical Device Sales(The operating permit);Conference Services;drug sales(The operating permit).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Jiangsu Beike Biotechnology Co., Ltd., established on 2008-02-19, Business scope includes biological products,biomedicine,Research and Development of Biomaterials,technical consulting,technology transfer,Provide management program services for medical institutions,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export),Storage and Preparation of Stem Cells,Storage and preparation of immune cells.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.

Boya Stem Cell Technology Co. Ltd. develops stem cell technology products. The company is headquartered in Wuxi, China.

Guangdong Weitai Biotechnology Co., Ltd., established on 2015-11-04, The scope of business includes research on stem cell and immune cell biotechnology and its biological products,to develop,Production,Sales and Applications;Collection of stem cells and immune cells,Storage and custody services;Research on genetic detection technology and its reagent products and instruments,to develop,Production,Sales;Gene drug development;Cell and gene-related technology transfer,Technical Services,technical consulting,Technical Training;Clinical Laboratory Services;Biomedical Technology Research;Provide management program services for medical institutions;Import and export,Technology Import and Export.Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Technology intermediary service;Quality inspection technical service;outpatient department(Place);nursing home;trade agent;Wholesale of cosmetics and hygiene products;Western medicine wholesale;Wholesale of nutrition and health products;Wholesale of medical supplies and equipment;Retailing of cosmetics and hygiene products;Nutrition and Supplement Retailing;Biopharmaceutical Manufacturing;Cosmetic Manufacturing;Health food manufacturing;Nutritional Food Manufacturing;dairy manufacturing;Manufacturing of chemical raw materials;Chemical Reagent and Auxiliary Manufacturing.(above production,Manufacturing items limited to branch operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Furuya Biotechnology Co., Ltd., established on 2019-03-26, Business scope includes biotechnology extension services;Biotechnology,stem cell technology,Stem Cell Drug Technology,Cosmetic Technology,Skin care technology development,Serve,transfer,consult;Medical Research and Experimental Development;Goods and technology import and export business;medical instruments(The operating permit),cosmetic,Wholesale and retail of laboratory instruments and equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)